AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Jul 2012 07:05 AM
RNS
Transaction in Own Shares
26 Jul 2012 07:00 AM
RNS
Pipeline table: Second Quarter & Half Year(2 of 2)
26 Jul 2012 07:00 AM
RNS
Second Quarter & Half Year Results (1 of 2)
25 Jul 2012 09:00 AM
RNS
Notice of Results
25 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
24 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
23 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
20 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
19 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
18 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
17 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
16 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
13 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
12 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
11 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
10 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
09 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
06 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
05 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
04 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
03 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
02 Jul 2012 04:00 PM
RNS
Total Voting Rights
02 Jul 2012 07:00 AM
RNS
AZ expands alliance with BMS through Amlyn
02 Jul 2012 07:00 AM
RNS
Transaction in Own Shares
29 Jun 2012 02:45 PM
RNS
Publication of Prospectus
29 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
28 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
27 Jun 2012 12:01 PM
RNS
AstraZeneca and Merck agree to amend second option
27 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
26 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
25 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
22 Jun 2012 12:24 PM
RNS
Zinforo receives positive CHMP opinion in the EU
22 Jun 2012 09:00 AM
RNS
Share Repurchase Programme
22 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
21 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
20 Jun 2012 07:00 AM
RNS
AstraZeneca completes acquisition of Ardea
19 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
18 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
15 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
14 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
08 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
07 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
06 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
01 Jun 2012 04:30 PM
RNS
Blocklisting Interim Review
01 Jun 2012 04:00 PM
RNS
Total Voting Rights
01 Jun 2012 07:00 AM
RNS
Transaction in Own Shares
31 May 2012 04:30 PM
RNS
Director/PDMR Shareholding
31 May 2012 07:00 AM
RNS
Transaction in Own Shares
30 May 2012 07:00 AM
RNS
Transaction in Own Shares
28 May 2012 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings